Sidley advised Akeso Inc. on the deal. Akeso Inc. announced a high-profile US$5 billion collaboration and licensing agreement with Summit Therapeutics Inc. to out-license its breakthrough bispecific...
You must be a Standard 1 Year member to access this content.
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
You must be a Standard 1 Year member to access this content.
Cooley advised Avant on the deal. Avant, a credit-first financial technology company, announced that it secured $250 million of corporate debt and redeemable preferred equity from...
You must be a Standard 1 Year member to access this content.
Cooley advised Drata on the deal. Drata, a continuous security and compliance automation platform, announced its $200 million Series C funding round. The latest round of funding,...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Apollo Endosurgery on the deal, while Shearman & Sterling advised Boston Scientific Corporation. Apollo Endosurgery, a medical device company, signed the agreement to be...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055...
You must be a Standard 1 Year member to access this content.
Cooley advised Neogene Therapeutics on the deal. Neogene Therapeutics, a global clinical-stage biotechnology company, signed its definitive agreement to be acquired by AstraZeneca for a total consideration...
You must be a Standard 1 Year member to access this content.
Cooley represented Zoetis, while Davis Polk advised the joint book-running managers in the offering. Zoetis Inc. executed its offering of $600 million aggregate principal amount of its...
You must be a Standard 1 Year member to access this content.
Cooley advised Ascend Vietnam Ventures on the deal. Ascend Vietnam Ventures exceeded the $50 million target for its flagship early-stage venture capital fund, AVV Alpha. AVV...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP and Morrison Foerster assisted MTY Food Group Inc. on the deal. MTY Food Group Inc. (MTY) announced that one of its wholly...
You must be a Standard 1 Year member to access this content.
Cooley advised Oyster Point Pharma on the deal, while Cravath represented Viatris. Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, announced its definitive agreement to be acquired...
You must be a Standard 1 Year member to access this content.
Bird & Bird and Cooley advised Munich-based tech start-up Software Defined Automation GmbH. Lead investor was the US Venture Capital firm Insight Partners and included the...
You must be a Standard 1 Year member to access this content.
